US 7345054
Heterocyclic inhibitors of ERK2 and uses thereof
granted A61PA61P35/00
Quick answer
US patent 7345054 (Heterocyclic inhibitors of ERK2 and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00